People with Alzheimer's have blood vessels that don't respond as well to signals that make them open up, even after taking a supplement called nitrate—which normally helps blood flow better—compared to older healthy people and young people.

To test whether vascular responsiveness differs between individuals with Alzheimer's Disease, healthy elderly, and young individuals after acute nitrate supplementation, the ideal study would recruit three age- and sex-matched groups (Alzheimer's, healthy elderly, young), administer a single oral or IV dose of nitrate (e.g., sodium nitrate or beetroot juice) and a placebo in randomized order with washout periods, and measure vascular responsiveness using gold-standard methods like flow-mediated dilation (FMD) or laser Doppler imaging before and after each intervention.

To compare vascular responsiveness between individuals with Alzheimer's Disease and matched healthy controls (elderly and young) after a single dose of nitrate, without randomization.

To observe natural variation in vascular responsiveness to acute nitrate across age and disease status without intervention.

To explore biological plausibility of reduced vascular responsiveness to nitrate in Alzheimer's pathology using controlled animal models.

To test whether vascular tissue from Alzheimer's patients responds differently to nitrate at the cellular level.